Candriam S.C.A. Tandem Diabetes Care Inc Transaction History

Candriam S.C.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$35.86 - $46.5 $645,480 - $837,000	18,000 Added 96.84%	36,587 $1.49 Million
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $851,334 - $1.35 Million	-23,988 Reduced 56.34%	18,587 $835,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $68.97 $3.57 Million - $5.62 Million	-81,499 Reduced 65.69%	42,575 $2.04 Million
Q2 2022 Aug 03, 2022	BUY	$53.22 - $123.09 $4.34 Million - $10 Million	81,499 Added 191.42%	124,074 $7.34 Million
Q1 2022 May 13, 2022	BUY	$101.89 - $150.09 $701,716 - $1.03 Million	6,887 Added 19.3%	42,575 $4.95 Million
Q4 2021 Feb 10, 2022	BUY	$118.18 - $153.21 $11,936 - $15,474	101 Added 0.28%	35,688 $5.37 Million
Q3 2021 Nov 09, 2021	SELL	$93.51 - $129.4 $3.55 Million - $4.92 Million	-38,000 Reduced 51.64%	35,587 $4.25 Million
Q2 2021 Jul 20, 2021	BUY	$77.0 - $100.19 $1.63 Million - $2.13 Million	21,217 Added 40.51%	73,587 $7.17 Million
Q4 2020 Jan 22, 2021	BUY	$86.4 - $121.75 $1.76 Million - $2.48 Million	20,370 Added 63.66%	52,370 $5.01 Million
Q3 2020 Oct 19, 2020	SELL	$95.43 - $116.09 $286,290 - $348,270	-3,000 Reduced 8.57%	32,000 $3.63 Million
Q2 2020 Jul 23, 2020	BUY	$60.05 - $98.92 $2.1 Million - $3.46 Million	35,000 New	35,000 $3.46 Million

359

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.